Dosing implications of rapid elimination of trimethoprim-sulfamethoxazole in patients with cystic fibrosis
- 1 February 1984
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 104 (2) , 303-307
- https://doi.org/10.1016/s0022-3476(84)81019-7
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Fixed Combination Drug TherapyDrugs, 1982
- Trimethoprim-sulfamethoxazole compared with ampicillin in the treatment of acute otitis mediaThe Journal of Pediatrics, 1980
- Intravenous trimethoprim-sulfamethoxazole in the treatment of serious infections in childrenThe Journal of Pediatrics, 1979
- Pharmacokinetics of Methicillin in Patients with Cystic FibrosisThe Journal of Infectious Diseases, 1977
- TREATMENT OF MENINGITIS and SEPTICEMIA IN INFANCY WITH A SULPHAMETHOXAZOLE/TRIMETHOPRIM COMBINATIONActa Paediatrica, 1975
- Pharmacokinetic Profile of Trimethoprim-Sulfamethoxazole in ManThe Journal of Infectious Diseases, 1973
- Trimethoprim-Sulfamethoxazole: In Vitro Microbiological AspectsThe Journal of Infectious Diseases, 1973
- Trimethoprim-Sulfamethoxazole in Children: Pharmacokinetics and Clinical StudiesThe Journal of Infectious Diseases, 1973
- Synergistic Activity of Trimethoprim-Sulfamethoxazole on Gram-Negative Bacilli: Observations In Vitro and In VivoThe Journal of Infectious Diseases, 1973
- Pharmacokinetics of Sulfamethoxazole + Trimethoprim in Man and Their Distribution in the RatChemotherapy, 1970